nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CYP3A4—Temozolomide—melanoma	0.0393	0.385	CbGbCtD
Galantamine—CYP2D6—Vemurafenib—melanoma	0.0339	0.332	CbGbCtD
Galantamine—CHRNA10—ear—melanoma	0.0293	0.143	CbGeAlD
Galantamine—CYP3A4—Vemurafenib—melanoma	0.0215	0.211	CbGbCtD
Galantamine—CHRNA3—skin epidermis—melanoma	0.0151	0.0734	CbGeAlD
Galantamine—CHRNA9—mammalian vulva—melanoma	0.0138	0.0674	CbGeAlD
Galantamine—CHRNA5—eye—melanoma	0.0127	0.0619	CbGeAlD
Galantamine—CHRNA7—skin epidermis—melanoma	0.00985	0.048	CbGeAlD
Galantamine—CHRNA6—skin of body—melanoma	0.00839	0.0408	CbGeAlD
Galantamine—CYP3A4—Docetaxel—melanoma	0.00739	0.0724	CbGbCtD
Galantamine—CHRNA5—head—melanoma	0.00722	0.0352	CbGeAlD
Galantamine—CHRNB3—head—melanoma	0.00656	0.0319	CbGeAlD
Galantamine—CHRNA6—head—melanoma	0.00547	0.0266	CbGeAlD
Galantamine—CHRNA3—eye—melanoma	0.00537	0.0261	CbGeAlD
Galantamine—CHRNA3—retina—melanoma	0.00532	0.0259	CbGeAlD
Galantamine—CHRNG—head—melanoma	0.00516	0.0251	CbGeAlD
Galantamine—CHRNA5—lymph node—melanoma	0.00506	0.0246	CbGeAlD
Galantamine—CHRNB4—head—melanoma	0.00497	0.0242	CbGeAlD
Galantamine—CHRNA7—neck—melanoma	0.00472	0.023	CbGeAlD
Galantamine—CHRNA3—skin of body—melanoma	0.00467	0.0227	CbGeAlD
Galantamine—CHRNB1—eye—melanoma	0.00465	0.0226	CbGeAlD
Galantamine—CHRNB2—mammalian vulva—melanoma	0.00439	0.0214	CbGeAlD
Galantamine—CHRNA10—head—melanoma	0.00437	0.0213	CbGeAlD
Galantamine—CHRNA7—eye—melanoma	0.00351	0.0171	CbGeAlD
Galantamine—CHRNA7—retina—melanoma	0.00348	0.0169	CbGeAlD
Galantamine—CHRNA1—head—melanoma	0.00342	0.0166	CbGeAlD
Galantamine—CHRNB2—head—melanoma	0.00314	0.0153	CbGeAlD
Galantamine—CHRNA10—lymph node—melanoma	0.00306	0.0149	CbGeAlD
Galantamine—CHRNA7—skin of body—melanoma	0.00305	0.0149	CbGeAlD
Galantamine—CHRNA3—head—melanoma	0.00305	0.0148	CbGeAlD
Galantamine—CHRNA2—head—melanoma	0.00283	0.0138	CbGeAlD
Galantamine—CHRNB1—head—melanoma	0.00264	0.0128	CbGeAlD
Galantamine—CHRFAM7A—head—melanoma	0.00247	0.012	CbGeAlD
Galantamine—CHRNB2—lymph node—melanoma	0.0022	0.0107	CbGeAlD
Galantamine—CHRNA3—lymph node—melanoma	0.00213	0.0104	CbGeAlD
Galantamine—CHRNA7—head—melanoma	0.00199	0.00969	CbGeAlD
Galantamine—CHRNA4—head—melanoma	0.00196	0.00956	CbGeAlD
Galantamine—CHRNB1—lymph node—melanoma	0.00185	0.00899	CbGeAlD
Galantamine—BCHE—skin of body—melanoma	0.00172	0.00838	CbGeAlD
Galantamine—ACHE—lymph node—melanoma	0.0016	0.00779	CbGeAlD
Galantamine—BCHE—mammalian vulva—melanoma	0.00157	0.00765	CbGeAlD
Galantamine—Urinary tract infection—Carmustine—melanoma	0.00146	0.00337	CcSEcCtD
Galantamine—Pneumonia—Temozolomide—melanoma	0.00146	0.00337	CcSEcCtD
Galantamine—Depression—Temozolomide—melanoma	0.00145	0.00334	CcSEcCtD
Galantamine—Hepatitis—Dactinomycin—melanoma	0.00144	0.00333	CcSEcCtD
Galantamine—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00144	0.00333	CcSEcCtD
Galantamine—Flushing—Bleomycin—melanoma	0.00143	0.00331	CcSEcCtD
Galantamine—Body temperature increased—Vemurafenib—melanoma	0.00143	0.00331	CcSEcCtD
Galantamine—Neuropathy peripheral—Temozolomide—melanoma	0.00142	0.00329	CcSEcCtD
Galantamine—Urinary tract infection—Temozolomide—melanoma	0.00141	0.00326	CcSEcCtD
Galantamine—Hepatobiliary disease—Temozolomide—melanoma	0.00137	0.00317	CcSEcCtD
Galantamine—Haemoglobin—Carmustine—melanoma	0.00135	0.00313	CcSEcCtD
Galantamine—Haemorrhage—Carmustine—melanoma	0.00135	0.00312	CcSEcCtD
Galantamine—Hallucination—Carmustine—melanoma	0.00134	0.0031	CcSEcCtD
Galantamine—Flushing—Dactinomycin—melanoma	0.00134	0.00309	CcSEcCtD
Galantamine—Hypersensitivity—Vemurafenib—melanoma	0.00133	0.00308	CcSEcCtD
Galantamine—Oedema peripheral—Carmustine—melanoma	0.00133	0.00307	CcSEcCtD
Galantamine—Connective tissue disorder—Carmustine—melanoma	0.00132	0.00306	CcSEcCtD
Galantamine—Atrial fibrillation—Docetaxel—melanoma	0.00132	0.00305	CcSEcCtD
Galantamine—Renal impairment—Docetaxel—melanoma	0.00132	0.00304	CcSEcCtD
Galantamine—Haemoglobin—Temozolomide—melanoma	0.00131	0.00303	CcSEcCtD
Galantamine—Hepatitis—Temozolomide—melanoma	0.0013	0.00301	CcSEcCtD
Galantamine—Haemorrhage—Temozolomide—melanoma	0.0013	0.00301	CcSEcCtD
Galantamine—Asthenia—Vemurafenib—melanoma	0.0013	0.003	CcSEcCtD
Galantamine—Visual impairment—Carmustine—melanoma	0.0013	0.003	CcSEcCtD
Galantamine—Hallucination—Temozolomide—melanoma	0.0013	0.003	CcSEcCtD
Galantamine—Urinary tract disorder—Temozolomide—melanoma	0.00129	0.00297	CcSEcCtD
Galantamine—Oedema peripheral—Temozolomide—melanoma	0.00128	0.00297	CcSEcCtD
Galantamine—Cardiac failure—Docetaxel—melanoma	0.00128	0.00297	CcSEcCtD
Galantamine—Connective tissue disorder—Temozolomide—melanoma	0.00128	0.00296	CcSEcCtD
Galantamine—Lethargy—Docetaxel—melanoma	0.00128	0.00295	CcSEcCtD
Galantamine—Urethral disorder—Temozolomide—melanoma	0.00128	0.00295	CcSEcCtD
Galantamine—Eye disorder—Carmustine—melanoma	0.00126	0.00291	CcSEcCtD
Galantamine—Visual impairment—Temozolomide—melanoma	0.00125	0.0029	CcSEcCtD
Galantamine—Pain in extremity—Docetaxel—melanoma	0.00125	0.00289	CcSEcCtD
Galantamine—Flushing—Carmustine—melanoma	0.00125	0.00289	CcSEcCtD
Galantamine—Ill-defined disorder—Bleomycin—melanoma	0.00125	0.00288	CcSEcCtD
Galantamine—Anaemia—Bleomycin—melanoma	0.00124	0.00287	CcSEcCtD
Galantamine—Diarrhoea—Vemurafenib—melanoma	0.00124	0.00286	CcSEcCtD
Galantamine—Eye disorder—Temozolomide—melanoma	0.00122	0.00281	CcSEcCtD
Galantamine—Tinnitus—Temozolomide—melanoma	0.00121	0.00281	CcSEcCtD
Galantamine—Malaise—Bleomycin—melanoma	0.00121	0.0028	CcSEcCtD
Galantamine—Flushing—Temozolomide—melanoma	0.00121	0.00279	CcSEcCtD
Galantamine—Cardiac disorder—Temozolomide—melanoma	0.00121	0.00279	CcSEcCtD
Galantamine—Arrhythmia—Carmustine—melanoma	0.0012	0.00278	CcSEcCtD
Galantamine—Dizziness—Vemurafenib—melanoma	0.0012	0.00277	CcSEcCtD
Galantamine—Angiopathy—Temozolomide—melanoma	0.00118	0.00273	CcSEcCtD
Galantamine—Mental disorder—Carmustine—melanoma	0.00118	0.00273	CcSEcCtD
Galantamine—Ataxia—Docetaxel—melanoma	0.00118	0.00272	CcSEcCtD
Galantamine—Immune system disorder—Temozolomide—melanoma	0.00118	0.00272	CcSEcCtD
Galantamine—Malnutrition—Carmustine—melanoma	0.00117	0.00271	CcSEcCtD
Galantamine—Cough—Bleomycin—melanoma	0.00117	0.00271	CcSEcCtD
Galantamine—Dehydration—Docetaxel—melanoma	0.00116	0.00269	CcSEcCtD
Galantamine—Ill-defined disorder—Dactinomycin—melanoma	0.00116	0.00269	CcSEcCtD
Galantamine—Anaemia—Dactinomycin—melanoma	0.00116	0.00268	CcSEcCtD
Galantamine—Vomiting—Vemurafenib—melanoma	0.00115	0.00266	CcSEcCtD
Galantamine—Chest pain—Bleomycin—melanoma	0.00114	0.00265	CcSEcCtD
Galantamine—Myalgia—Bleomycin—melanoma	0.00114	0.00265	CcSEcCtD
Galantamine—Orthostatic hypotension—Docetaxel—melanoma	0.00114	0.00264	CcSEcCtD
Galantamine—Abdominal pain upper—Docetaxel—melanoma	0.00114	0.00264	CcSEcCtD
Galantamine—Rash—Vemurafenib—melanoma	0.00114	0.00264	CcSEcCtD
Galantamine—Mental disorder—Temozolomide—melanoma	0.00114	0.00264	CcSEcCtD
Galantamine—Dermatitis—Vemurafenib—melanoma	0.00114	0.00264	CcSEcCtD
Galantamine—Back pain—Carmustine—melanoma	0.00113	0.00262	CcSEcCtD
Galantamine—Headache—Vemurafenib—melanoma	0.00113	0.00262	CcSEcCtD
Galantamine—Malnutrition—Temozolomide—melanoma	0.00113	0.00262	CcSEcCtD
Galantamine—Discomfort—Bleomycin—melanoma	0.00113	0.00261	CcSEcCtD
Galantamine—Malaise—Dactinomycin—melanoma	0.00113	0.00261	CcSEcCtD
Galantamine—BCHE—head—melanoma	0.00112	0.00547	CbGeAlD
Galantamine—Dysgeusia—Temozolomide—melanoma	0.00111	0.00257	CcSEcCtD
Galantamine—Confusional state—Bleomycin—melanoma	0.00111	0.00256	CcSEcCtD
Galantamine—Vision blurred—Carmustine—melanoma	0.00111	0.00256	CcSEcCtD
Galantamine—Tremor—Carmustine—melanoma	0.0011	0.00254	CcSEcCtD
Galantamine—Back pain—Temozolomide—melanoma	0.0011	0.00254	CcSEcCtD
Galantamine—Anaemia—Carmustine—melanoma	0.00108	0.00251	CcSEcCtD
Galantamine—Dysphagia—Docetaxel—melanoma	0.00108	0.0025	CcSEcCtD
Galantamine—Agitation—Carmustine—melanoma	0.00108	0.00249	CcSEcCtD
Galantamine—Nausea—Vemurafenib—melanoma	0.00108	0.00249	CcSEcCtD
Galantamine—Thrombocytopenia—Bleomycin—melanoma	0.00107	0.00248	CcSEcCtD
Galantamine—Vision blurred—Temozolomide—melanoma	0.00107	0.00247	CcSEcCtD
Galantamine—Myalgia—Dactinomycin—melanoma	0.00107	0.00247	CcSEcCtD
Galantamine—Tremor—Temozolomide—melanoma	0.00106	0.00246	CcSEcCtD
Galantamine—Discomfort—Dactinomycin—melanoma	0.00105	0.00244	CcSEcCtD
Galantamine—Ill-defined disorder—Temozolomide—melanoma	0.00105	0.00243	CcSEcCtD
Galantamine—Anaemia—Temozolomide—melanoma	0.00105	0.00242	CcSEcCtD
Galantamine—Anorexia—Bleomycin—melanoma	0.00105	0.00242	CcSEcCtD
Galantamine—Agitation—Temozolomide—melanoma	0.00104	0.00241	CcSEcCtD
Galantamine—Hypotension—Bleomycin—melanoma	0.00102	0.00237	CcSEcCtD
Galantamine—Malaise—Temozolomide—melanoma	0.00102	0.00236	CcSEcCtD
Galantamine—Vertigo—Temozolomide—melanoma	0.00102	0.00236	CcSEcCtD
Galantamine—Convulsion—Carmustine—melanoma	0.00102	0.00235	CcSEcCtD
Galantamine—Hypertension—Carmustine—melanoma	0.00101	0.00234	CcSEcCtD
Galantamine—Palpitations—Temozolomide—melanoma	0.001	0.00232	CcSEcCtD
Galantamine—Thrombocytopenia—Dactinomycin—melanoma	0.001	0.00232	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000999	0.00231	CcSEcCtD
Galantamine—Myalgia—Carmustine—melanoma	0.000999	0.00231	CcSEcCtD
Galantamine—Chest pain—Carmustine—melanoma	0.000999	0.00231	CcSEcCtD
Galantamine—Anxiety—Carmustine—melanoma	0.000995	0.0023	CcSEcCtD
Galantamine—Cough—Temozolomide—melanoma	0.000989	0.00229	CcSEcCtD
Galantamine—Paraesthesia—Bleomycin—melanoma	0.000985	0.00228	CcSEcCtD
Galantamine—Convulsion—Temozolomide—melanoma	0.000982	0.00227	CcSEcCtD
Galantamine—Weight decreased—Docetaxel—melanoma	0.000979	0.00226	CcSEcCtD
Galantamine—Hypertension—Temozolomide—melanoma	0.000979	0.00226	CcSEcCtD
Galantamine—Anorexia—Dactinomycin—melanoma	0.000975	0.00225	CcSEcCtD
Galantamine—Pneumonia—Docetaxel—melanoma	0.00097	0.00224	CcSEcCtD
Galantamine—Confusional state—Carmustine—melanoma	0.000965	0.00223	CcSEcCtD
Galantamine—Myalgia—Temozolomide—melanoma	0.000965	0.00223	CcSEcCtD
Galantamine—Arthralgia—Temozolomide—melanoma	0.000965	0.00223	CcSEcCtD
Galantamine—Anxiety—Temozolomide—melanoma	0.000962	0.00222	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000958	0.00222	CcSEcCtD
Galantamine—Discomfort—Temozolomide—melanoma	0.000954	0.00221	CcSEcCtD
Galantamine—Decreased appetite—Bleomycin—melanoma	0.000953	0.0022	CcSEcCtD
Galantamine—Renal failure—Docetaxel—melanoma	0.000948	0.00219	CcSEcCtD
Galantamine—Neuropathy peripheral—Docetaxel—melanoma	0.000946	0.00219	CcSEcCtD
Galantamine—Dry mouth—Temozolomide—melanoma	0.000944	0.00218	CcSEcCtD
Galantamine—Thrombocytopenia—Carmustine—melanoma	0.000937	0.00217	CcSEcCtD
Galantamine—Tachycardia—Carmustine—melanoma	0.000934	0.00216	CcSEcCtD
Galantamine—Confusional state—Temozolomide—melanoma	0.000933	0.00216	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000932	0.00216	CcSEcCtD
Galantamine—Anorexia—Carmustine—melanoma	0.000913	0.00211	CcSEcCtD
Galantamine—Hepatobiliary disease—Docetaxel—melanoma	0.000912	0.00211	CcSEcCtD
Galantamine—Epistaxis—Docetaxel—melanoma	0.00091	0.0021	CcSEcCtD
Galantamine—Nervous system disorder—Temozolomide—melanoma	0.000907	0.0021	CcSEcCtD
Galantamine—Thrombocytopenia—Temozolomide—melanoma	0.000906	0.00209	CcSEcCtD
Galantamine—Feeling abnormal—Bleomycin—melanoma	0.000904	0.00209	CcSEcCtD
Galantamine—Skin disorder—Temozolomide—melanoma	0.000899	0.00208	CcSEcCtD
Galantamine—Hypotension—Carmustine—melanoma	0.000895	0.00207	CcSEcCtD
Galantamine—Hyperhidrosis—Temozolomide—melanoma	0.000894	0.00207	CcSEcCtD
Galantamine—Decreased appetite—Dactinomycin—melanoma	0.000889	0.00206	CcSEcCtD
Galantamine—Fatigue—Dactinomycin—melanoma	0.000882	0.00204	CcSEcCtD
Galantamine—Anorexia—Temozolomide—melanoma	0.000882	0.00204	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Carmustine—melanoma	0.000872	0.00202	CcSEcCtD
Galantamine—Haemoglobin—Docetaxel—melanoma	0.00087	0.00201	CcSEcCtD
Galantamine—Rhinitis—Docetaxel—melanoma	0.000868	0.00201	CcSEcCtD
Galantamine—Body temperature increased—Bleomycin—melanoma	0.000867	0.002	CcSEcCtD
Galantamine—Haemorrhage—Docetaxel—melanoma	0.000866	0.002	CcSEcCtD
Galantamine—Hepatitis—Docetaxel—melanoma	0.000866	0.002	CcSEcCtD
Galantamine—Insomnia—Carmustine—melanoma	0.000866	0.002	CcSEcCtD
Galantamine—Paraesthesia—Carmustine—melanoma	0.00086	0.00199	CcSEcCtD
Galantamine—Urinary tract disorder—Docetaxel—melanoma	0.000855	0.00198	CcSEcCtD
Galantamine—Oedema peripheral—Docetaxel—melanoma	0.000853	0.00197	CcSEcCtD
Galantamine—Somnolence—Carmustine—melanoma	0.000851	0.00197	CcSEcCtD
Galantamine—Connective tissue disorder—Docetaxel—melanoma	0.000851	0.00197	CcSEcCtD
Galantamine—Urethral disorder—Docetaxel—melanoma	0.000849	0.00196	CcSEcCtD
Galantamine—Feeling abnormal—Dactinomycin—melanoma	0.000843	0.00195	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000843	0.00195	CcSEcCtD
Galantamine—Insomnia—Temozolomide—melanoma	0.000837	0.00194	CcSEcCtD
Galantamine—Gastrointestinal pain—Dactinomycin—melanoma	0.000836	0.00193	CcSEcCtD
Galantamine—Visual impairment—Docetaxel—melanoma	0.000835	0.00193	CcSEcCtD
Galantamine—Decreased appetite—Carmustine—melanoma	0.000832	0.00192	CcSEcCtD
Galantamine—Paraesthesia—Temozolomide—melanoma	0.000831	0.00192	CcSEcCtD
Galantamine—Gastrointestinal disorder—Carmustine—melanoma	0.000827	0.00191	CcSEcCtD
Galantamine—Somnolence—Temozolomide—melanoma	0.000823	0.0019	CcSEcCtD
Galantamine—Constipation—Carmustine—melanoma	0.000819	0.00189	CcSEcCtD
Galantamine—Dyspepsia—Temozolomide—melanoma	0.000814	0.00188	CcSEcCtD
Galantamine—Eye disorder—Docetaxel—melanoma	0.000809	0.00187	CcSEcCtD
Galantamine—Abdominal pain—Dactinomycin—melanoma	0.000809	0.00187	CcSEcCtD
Galantamine—Body temperature increased—Dactinomycin—melanoma	0.000809	0.00187	CcSEcCtD
Galantamine—Hypersensitivity—Bleomycin—melanoma	0.000808	0.00187	CcSEcCtD
Galantamine—Decreased appetite—Temozolomide—melanoma	0.000804	0.00186	CcSEcCtD
Galantamine—Cardiac disorder—Docetaxel—melanoma	0.000804	0.00186	CcSEcCtD
Galantamine—Flushing—Docetaxel—melanoma	0.000804	0.00186	CcSEcCtD
Galantamine—Gastrointestinal disorder—Temozolomide—melanoma	0.000799	0.00185	CcSEcCtD
Galantamine—Fatigue—Temozolomide—melanoma	0.000798	0.00184	CcSEcCtD
Galantamine—Constipation—Temozolomide—melanoma	0.000791	0.00183	CcSEcCtD
Galantamine—Feeling abnormal—Carmustine—melanoma	0.000789	0.00182	CcSEcCtD
Galantamine—Asthenia—Bleomycin—melanoma	0.000787	0.00182	CcSEcCtD
Galantamine—BCHE—lymph node—melanoma	0.000787	0.00383	CbGeAlD
Galantamine—Angiopathy—Docetaxel—melanoma	0.000786	0.00182	CcSEcCtD
Galantamine—Gastrointestinal pain—Carmustine—melanoma	0.000783	0.00181	CcSEcCtD
Galantamine—Immune system disorder—Docetaxel—melanoma	0.000782	0.00181	CcSEcCtD
Galantamine—Arrhythmia—Docetaxel—melanoma	0.000774	0.00179	CcSEcCtD
Galantamine—Feeling abnormal—Temozolomide—melanoma	0.000762	0.00176	CcSEcCtD
Galantamine—Mental disorder—Docetaxel—melanoma	0.000759	0.00175	CcSEcCtD
Galantamine—Abdominal pain—Carmustine—melanoma	0.000757	0.00175	CcSEcCtD
Galantamine—Body temperature increased—Carmustine—melanoma	0.000757	0.00175	CcSEcCtD
Galantamine—Gastrointestinal pain—Temozolomide—melanoma	0.000757	0.00175	CcSEcCtD
Galantamine—Malnutrition—Docetaxel—melanoma	0.000754	0.00174	CcSEcCtD
Galantamine—Hypersensitivity—Dactinomycin—melanoma	0.000754	0.00174	CcSEcCtD
Galantamine—CYP2D6—head—melanoma	0.000744	0.00362	CbGeAlD
Galantamine—Dysgeusia—Docetaxel—melanoma	0.000738	0.00171	CcSEcCtD
Galantamine—Asthenia—Dactinomycin—melanoma	0.000734	0.0017	CcSEcCtD
Galantamine—Body temperature increased—Temozolomide—melanoma	0.000731	0.00169	CcSEcCtD
Galantamine—Abdominal pain—Temozolomide—melanoma	0.000731	0.00169	CcSEcCtD
Galantamine—Back pain—Docetaxel—melanoma	0.000729	0.00169	CcSEcCtD
Galantamine—Muscle spasms—Docetaxel—melanoma	0.000725	0.00168	CcSEcCtD
Galantamine—Hypersensitivity—Carmustine—melanoma	0.000705	0.00163	CcSEcCtD
Galantamine—Diarrhoea—Dactinomycin—melanoma	0.0007	0.00162	CcSEcCtD
Galantamine—Vomiting—Bleomycin—melanoma	0.000697	0.00161	CcSEcCtD
Galantamine—Anaemia—Docetaxel—melanoma	0.000697	0.00161	CcSEcCtD
Galantamine—Rash—Bleomycin—melanoma	0.000692	0.0016	CcSEcCtD
Galantamine—Dermatitis—Bleomycin—melanoma	0.000691	0.0016	CcSEcCtD
Galantamine—Asthenia—Carmustine—melanoma	0.000687	0.00159	CcSEcCtD
Galantamine—Hypersensitivity—Temozolomide—melanoma	0.000682	0.00158	CcSEcCtD
Galantamine—Syncope—Docetaxel—melanoma	0.000676	0.00156	CcSEcCtD
Galantamine—Palpitations—Docetaxel—melanoma	0.000666	0.00154	CcSEcCtD
Galantamine—Asthenia—Temozolomide—melanoma	0.000664	0.00154	CcSEcCtD
Galantamine—Loss of consciousness—Docetaxel—melanoma	0.000663	0.00153	CcSEcCtD
Galantamine—Cough—Docetaxel—melanoma	0.000658	0.00152	CcSEcCtD
Galantamine—Diarrhoea—Carmustine—melanoma	0.000655	0.00151	CcSEcCtD
Galantamine—Convulsion—Docetaxel—melanoma	0.000653	0.00151	CcSEcCtD
Galantamine—Nausea—Bleomycin—melanoma	0.000651	0.00151	CcSEcCtD
Galantamine—Hypertension—Docetaxel—melanoma	0.000651	0.00151	CcSEcCtD
Galantamine—Vomiting—Dactinomycin—melanoma	0.00065	0.0015	CcSEcCtD
Galantamine—Rash—Dactinomycin—melanoma	0.000645	0.00149	CcSEcCtD
Galantamine—Myalgia—Docetaxel—melanoma	0.000642	0.00148	CcSEcCtD
Galantamine—Chest pain—Docetaxel—melanoma	0.000642	0.00148	CcSEcCtD
Galantamine—Arthralgia—Docetaxel—melanoma	0.000642	0.00148	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000637	0.00147	CcSEcCtD
Galantamine—Dizziness—Carmustine—melanoma	0.000633	0.00146	CcSEcCtD
Galantamine—Diarrhoea—Temozolomide—melanoma	0.000633	0.00146	CcSEcCtD
Galantamine—Dry mouth—Docetaxel—melanoma	0.000628	0.00145	CcSEcCtD
Galantamine—Confusional state—Docetaxel—melanoma	0.00062	0.00143	CcSEcCtD
Galantamine—Dizziness—Temozolomide—melanoma	0.000612	0.00141	CcSEcCtD
Galantamine—Vomiting—Carmustine—melanoma	0.000609	0.00141	CcSEcCtD
Galantamine—Nausea—Dactinomycin—melanoma	0.000608	0.00141	CcSEcCtD
Galantamine—Shock—Docetaxel—melanoma	0.000605	0.0014	CcSEcCtD
Galantamine—Rash—Carmustine—melanoma	0.000604	0.0014	CcSEcCtD
Galantamine—Nervous system disorder—Docetaxel—melanoma	0.000603	0.0014	CcSEcCtD
Galantamine—Dermatitis—Carmustine—melanoma	0.000603	0.00139	CcSEcCtD
Galantamine—Thrombocytopenia—Docetaxel—melanoma	0.000602	0.00139	CcSEcCtD
Galantamine—Tachycardia—Docetaxel—melanoma	0.0006	0.00139	CcSEcCtD
Galantamine—Headache—Carmustine—melanoma	0.0006	0.00139	CcSEcCtD
Galantamine—Skin disorder—Docetaxel—melanoma	0.000598	0.00138	CcSEcCtD
Galantamine—Vomiting—Temozolomide—melanoma	0.000588	0.00136	CcSEcCtD
Galantamine—Anorexia—Docetaxel—melanoma	0.000586	0.00136	CcSEcCtD
Galantamine—Rash—Temozolomide—melanoma	0.000583	0.00135	CcSEcCtD
Galantamine—Dermatitis—Temozolomide—melanoma	0.000583	0.00135	CcSEcCtD
Galantamine—Headache—Temozolomide—melanoma	0.00058	0.00134	CcSEcCtD
Galantamine—Hypotension—Docetaxel—melanoma	0.000575	0.00133	CcSEcCtD
Galantamine—Nausea—Carmustine—melanoma	0.000569	0.00132	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000561	0.0013	CcSEcCtD
Galantamine—Insomnia—Docetaxel—melanoma	0.000556	0.00129	CcSEcCtD
Galantamine—Paraesthesia—Docetaxel—melanoma	0.000552	0.00128	CcSEcCtD
Galantamine—Nausea—Temozolomide—melanoma	0.00055	0.00127	CcSEcCtD
Galantamine—Somnolence—Docetaxel—melanoma	0.000547	0.00126	CcSEcCtD
Galantamine—Dyspepsia—Docetaxel—melanoma	0.000542	0.00125	CcSEcCtD
Galantamine—Decreased appetite—Docetaxel—melanoma	0.000535	0.00124	CcSEcCtD
Galantamine—Gastrointestinal disorder—Docetaxel—melanoma	0.000531	0.00123	CcSEcCtD
Galantamine—Fatigue—Docetaxel—melanoma	0.00053	0.00123	CcSEcCtD
Galantamine—Constipation—Docetaxel—melanoma	0.000526	0.00122	CcSEcCtD
Galantamine—Feeling abnormal—Docetaxel—melanoma	0.000507	0.00117	CcSEcCtD
Galantamine—Gastrointestinal pain—Docetaxel—melanoma	0.000503	0.00116	CcSEcCtD
Galantamine—Body temperature increased—Docetaxel—melanoma	0.000486	0.00112	CcSEcCtD
Galantamine—Abdominal pain—Docetaxel—melanoma	0.000486	0.00112	CcSEcCtD
Galantamine—Hypersensitivity—Docetaxel—melanoma	0.000453	0.00105	CcSEcCtD
Galantamine—Asthenia—Docetaxel—melanoma	0.000441	0.00102	CcSEcCtD
Galantamine—Diarrhoea—Docetaxel—melanoma	0.000421	0.000973	CcSEcCtD
Galantamine—Dizziness—Docetaxel—melanoma	0.000407	0.000941	CcSEcCtD
Galantamine—Vomiting—Docetaxel—melanoma	0.000391	0.000905	CcSEcCtD
Galantamine—Rash—Docetaxel—melanoma	0.000388	0.000897	CcSEcCtD
Galantamine—Dermatitis—Docetaxel—melanoma	0.000388	0.000896	CcSEcCtD
Galantamine—Headache—Docetaxel—melanoma	0.000385	0.000891	CcSEcCtD
Galantamine—Nausea—Docetaxel—melanoma	0.000365	0.000845	CcSEcCtD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.00012	0.000461	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—PRKCA—melanoma	0.00012	0.000461	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—MAPK1—melanoma	0.00012	0.00046	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL6—melanoma	0.000119	0.000458	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000119	0.000458	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—HRAS—melanoma	0.000119	0.000457	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—HRAS—melanoma	0.000118	0.000452	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—MDM2—melanoma	0.000116	0.000447	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—BRAF—melanoma	0.000115	0.000443	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—HRAS—melanoma	0.000115	0.00044	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000114	0.000438	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—MAPK1—melanoma	0.000113	0.000436	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—MAPK1—melanoma	0.000112	0.000432	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000112	0.000432	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLCB4—melanoma	0.000112	0.000431	CbGpPWpGaD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000111	0.000426	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000111	0.000426	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00011	0.000423	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PTEN—melanoma	0.000109	0.00042	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000108	0.000416	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—MDM2—melanoma	0.000108	0.000416	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—HRAS—melanoma	0.000108	0.000414	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP1B1—melanoma	0.000107	0.000412	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000106	0.000409	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	0.000106	0.000406	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIP4K2A—melanoma	0.000105	0.000406	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC6A11—melanoma	0.000105	0.000406	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—MAPK1—melanoma	0.000104	0.000399	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PAX6—melanoma	0.000104	0.000398	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—MAPK1—melanoma	0.000103	0.000395	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MTAP—melanoma	0.000103	0.000395	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000103	0.000394	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—HRAS—melanoma	0.000102	0.000393	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—HRAS—melanoma	0.000101	0.000389	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.0001	0.000386	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.0001	0.000386	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLCB4—melanoma	0.0001	0.000385	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—HSPA5—melanoma	9.95e-05	0.000383	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—BRAF—melanoma	9.9e-05	0.000381	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—FASN—melanoma	9.82e-05	0.000378	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	9.78e-05	0.000376	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—MAPK1—melanoma	9.75e-05	0.000375	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL6—melanoma	9.72e-05	0.000374	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	9.69e-05	0.000372	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—MDM2—melanoma	9.66e-05	0.000371	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—MAPK1—melanoma	9.65e-05	0.000371	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—HRAS—melanoma	9.6e-05	0.000369	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	9.46e-05	0.000364	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	9.44e-05	0.000363	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIP4K2A—melanoma	9.41e-05	0.000362	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC6A11—melanoma	9.41e-05	0.000362	CbGpPWpGaD
Galantamine—CYP3A4—Tryptophan metabolism—MDM2—melanoma	9.41e-05	0.000362	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	9.4e-05	0.000361	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PAX6—melanoma	9.23e-05	0.000355	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—MAPK1—melanoma	9.16e-05	0.000352	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MTAP—melanoma	9.16e-05	0.000352	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PHGDH—melanoma	9.15e-05	0.000352	CbGpPWpGaD
Galantamine—ACHE—Metabolism—LUM—melanoma	9.15e-05	0.000352	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—HRAS—melanoma	9.11e-05	0.00035	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—HRAS—melanoma	9.02e-05	0.000347	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HPSE—melanoma	8.97e-05	0.000345	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	8.95e-05	0.000344	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—HSPA5—melanoma	8.88e-05	0.000341	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—BRAF—melanoma	8.83e-05	0.00034	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CUBN—melanoma	8.81e-05	0.000339	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3CA—melanoma	8.64e-05	0.000332	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	8.53e-05	0.000328	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SDHD—melanoma	8.5e-05	0.000327	CbGpPWpGaD
Galantamine—ACHE—Metabolism—BSG—melanoma	8.5e-05	0.000327	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CSPG4—melanoma	8.5e-05	0.000327	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—HRAS—melanoma	8.33e-05	0.00032	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP17A1—melanoma	8.32e-05	0.00032	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—MDM2—melanoma	8.29e-05	0.000319	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—HRAS—melanoma	8.25e-05	0.000317	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GPAM—melanoma	8.24e-05	0.000317	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	8.21e-05	0.000316	CbGpPWpGaD
Galantamine—BCHE—Metabolism—LUM—melanoma	8.16e-05	0.000314	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PHGDH—melanoma	8.16e-05	0.000314	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	8.07e-05	0.00031	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HPSE—melanoma	8e-05	0.000308	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—MAPK1—melanoma	7.95e-05	0.000306	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CUBN—melanoma	7.86e-05	0.000302	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—melanoma	7.85e-05	0.000302	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—HRAS—melanoma	7.83e-05	0.000301	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—HRAS—melanoma	7.74e-05	0.000298	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CA—melanoma	7.71e-05	0.000296	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	7.68e-05	0.000295	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	7.67e-05	0.000295	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SDHD—melanoma	7.59e-05	0.000292	CbGpPWpGaD
Galantamine—BCHE—Metabolism—BSG—melanoma	7.59e-05	0.000292	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CSPG4—melanoma	7.59e-05	0.000292	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—MDM2—melanoma	7.4e-05	0.000284	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—MAPK1—melanoma	7.4e-05	0.000284	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—HRAS—melanoma	7.36e-05	0.000283	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GPAM—melanoma	7.35e-05	0.000282	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—melanoma	7.31e-05	0.000281	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	7.25e-05	0.000279	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ACER3—melanoma	7.14e-05	0.000275	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP1B1—melanoma	7.01e-05	0.000269	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLA2G6—melanoma	7e-05	0.000269	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	6.91e-05	0.000266	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	6.66e-05	0.000256	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—MAPK1—melanoma	6.6e-05	0.000254	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—UGT2B10—melanoma	6.53e-05	0.000251	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—melanoma	6.44e-05	0.000248	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—HRAS—melanoma	6.38e-05	0.000245	CbGpPWpGaD
Galantamine—ACHE—Metabolism—VCAN—melanoma	6.29e-05	0.000242	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLA2G6—melanoma	6.25e-05	0.00024	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HS3ST5—melanoma	6.07e-05	0.000234	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.95e-05	0.000229	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—HRAS—melanoma	5.94e-05	0.000228	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP1—melanoma	5.89e-05	0.000227	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.75e-05	0.000221	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—MAPK1—melanoma	5.67e-05	0.000218	CbGpPWpGaD
Galantamine—BCHE—Metabolism—VCAN—melanoma	5.61e-05	0.000216	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	5.44e-05	0.000209	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.31e-05	0.000204	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP17A1—melanoma	5.31e-05	0.000204	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—HRAS—melanoma	5.3e-05	0.000204	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP1—melanoma	5.26e-05	0.000202	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.23e-05	0.000201	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALB—melanoma	5.17e-05	0.000199	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.13e-05	0.000197	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—MAPK1—melanoma	5.06e-05	0.000194	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GNA11—melanoma	5.01e-05	0.000193	CbGpPWpGaD
Galantamine—ACHE—Metabolism—FASN—melanoma	4.9e-05	0.000189	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC5A5—melanoma	4.82e-05	0.000185	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP17A1—melanoma	4.73e-05	0.000182	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGF1—melanoma	4.71e-05	0.000181	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ACER3—melanoma	4.67e-05	0.00018	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.67e-05	0.00018	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GNAQ—melanoma	4.66e-05	0.000179	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CD44—melanoma	4.66e-05	0.000179	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALB—melanoma	4.61e-05	0.000177	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLCB4—melanoma	4.6e-05	0.000177	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.56e-05	0.000175	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP2—melanoma	4.56e-05	0.000175	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—HRAS—melanoma	4.55e-05	0.000175	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.52e-05	0.000174	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GNA11—melanoma	4.47e-05	0.000172	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP1B1—melanoma	4.47e-05	0.000172	CbGpPWpGaD
Galantamine—BCHE—Metabolism—FASN—melanoma	4.38e-05	0.000168	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIP4K2A—melanoma	4.33e-05	0.000166	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC6A11—melanoma	4.33e-05	0.000166	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC5A5—melanoma	4.3e-05	0.000165	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—UGT2B10—melanoma	4.27e-05	0.000164	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTAP—melanoma	4.21e-05	0.000162	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF1—melanoma	4.2e-05	0.000162	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CD44—melanoma	4.16e-05	0.00016	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GNAQ—melanoma	4.16e-05	0.00016	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.07e-05	0.000156	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP2—melanoma	4.07e-05	0.000156	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—HRAS—melanoma	4.06e-05	0.000156	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.03e-05	0.000155	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP1B1—melanoma	3.99e-05	0.000153	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HS3ST5—melanoma	3.97e-05	0.000153	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.94e-05	0.000152	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CXCL8—melanoma	3.79e-05	0.000146	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PHGDH—melanoma	3.75e-05	0.000144	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LUM—melanoma	3.75e-05	0.000144	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HPSE—melanoma	3.68e-05	0.000141	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCB1—melanoma	3.68e-05	0.000141	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CUBN—melanoma	3.61e-05	0.000139	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.52e-05	0.000135	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CTNNB1—melanoma	3.5e-05	0.000134	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—BSG—melanoma	3.49e-05	0.000134	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CSPG4—melanoma	3.49e-05	0.000134	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SDHD—melanoma	3.49e-05	0.000134	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PRKCA—melanoma	3.39e-05	0.00013	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CXCL8—melanoma	3.38e-05	0.00013	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GPAM—melanoma	3.38e-05	0.00013	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ERCC2—melanoma	3.36e-05	0.000129	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCB1—melanoma	3.28e-05	0.000126	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CTNNB1—melanoma	3.12e-05	0.00012	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PRKCA—melanoma	3.02e-05	0.000116	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLCB4—melanoma	3.01e-05	0.000116	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ERCC2—melanoma	3e-05	0.000115	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLA2G6—melanoma	2.87e-05	0.00011	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC6A11—melanoma	2.83e-05	0.000109	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIP4K2A—melanoma	2.83e-05	0.000109	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.78e-05	0.000107	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTAP—melanoma	2.75e-05	0.000106	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CG—melanoma	2.65e-05	0.000102	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—VCAN—melanoma	2.58e-05	9.92e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPARG—melanoma	2.56e-05	9.84e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.48e-05	9.54e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PHGDH—melanoma	2.45e-05	9.43e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LUM—melanoma	2.45e-05	9.43e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HPSE—melanoma	2.41e-05	9.25e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CG—melanoma	2.37e-05	9.1e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CUBN—melanoma	2.36e-05	9.08e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CD—melanoma	2.33e-05	8.96e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALB—melanoma	2.3e-05	8.85e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPARG—melanoma	2.28e-05	8.78e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—BSG—melanoma	2.28e-05	8.77e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CSPG4—melanoma	2.28e-05	8.77e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SDHD—melanoma	2.28e-05	8.77e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GPAM—melanoma	2.21e-05	8.49e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP17A1—melanoma	2.18e-05	8.37e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CD—melanoma	2.08e-05	8e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GNA11—melanoma	2.06e-05	7.9e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALB—melanoma	2.05e-05	7.89e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CB—melanoma	2.03e-05	7.81e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—melanoma	2.01e-05	7.74e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—FASN—melanoma	2.01e-05	7.74e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC5A5—melanoma	1.98e-05	7.61e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GNAQ—melanoma	1.91e-05	7.35e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CD44—melanoma	1.91e-05	7.35e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLA2G6—melanoma	1.88e-05	7.22e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP1B1—melanoma	1.83e-05	7.05e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CB—melanoma	1.81e-05	6.97e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—melanoma	1.8e-05	6.91e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTEN—melanoma	1.76e-05	6.75e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—VCAN—melanoma	1.69e-05	6.49e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTEN—melanoma	1.57e-05	6.02e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCB1—melanoma	1.51e-05	5.8e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP17A1—melanoma	1.42e-05	5.47e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PRKCA—melanoma	1.39e-05	5.34e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ERCC2—melanoma	1.38e-05	5.3e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GNA11—melanoma	1.34e-05	5.17e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—FASN—melanoma	1.32e-05	5.06e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC5A5—melanoma	1.29e-05	4.97e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GNAQ—melanoma	1.25e-05	4.8e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CD44—melanoma	1.25e-05	4.8e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CA—melanoma	1.24e-05	4.76e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP1B1—melanoma	1.2e-05	4.61e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CA—melanoma	1.11e-05	4.25e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CG—melanoma	1.09e-05	4.18e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARG—melanoma	1.05e-05	4.04e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKT1—melanoma	1.01e-05	3.89e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCB1—melanoma	9.87e-06	3.79e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CD—melanoma	9.56e-06	3.68e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALB—melanoma	9.44e-06	3.63e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PRKCA—melanoma	9.08e-06	3.49e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKT1—melanoma	9.03e-06	3.47e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ERCC2—melanoma	9e-06	3.46e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CB—melanoma	8.33e-06	3.2e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—melanoma	8.26e-06	3.18e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTEN—melanoma	7.2e-06	2.77e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CG—melanoma	7.11e-06	2.73e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARG—melanoma	6.86e-06	2.64e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CD—melanoma	6.25e-06	2.4e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALB—melanoma	6.17e-06	2.37e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CB—melanoma	5.45e-06	2.1e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—melanoma	5.4e-06	2.08e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CA—melanoma	5.08e-06	1.95e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTEN—melanoma	4.71e-06	1.81e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKT1—melanoma	4.15e-06	1.6e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CA—melanoma	3.32e-06	1.28e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKT1—melanoma	2.71e-06	1.04e-05	CbGpPWpGaD
